Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 73.3 GBX -0.34% Market Closed
Market Cap: 706m GBX
Have any thoughts about
Dr Martens PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one DOCS stock under the Base Case scenario is 150.24 GBX. Compared to the current market price of 73.3 GBX, Dr Martens PLC is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DOCS Relative Value
Base Case
150.24 GBX
Undervaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
91
vs Industry
51
Median 3Y
1.4
Median 5Y
1.6
Industry
1
Forward
0.9
More Details
10.2
P/E
P/E
Price to Earnings
10.2
vs History
91
vs Industry
50
Median 3Y
11.3
Median 5Y
11.8
Industry
18.7
Forward
23.8
More Details
4.2
P/OCF
P/OCF
Price to OCF
4.2
vs History
91
vs Industry
55
Median 3Y
12.6
Median 5Y
13.7
Industry
10.1
More Details
9.4
P/FCFE
P/FCFE
Price to FCFE
9.4
vs History
66
vs Industry
36
Median 3Y
9.5
Median 5Y
10.8
Industry
17.3
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
95
vs Industry
30
Median 3Y
3.8
Median 5Y
4.6
Industry
1.4
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
91
vs Industry
42
Median 3Y
1.8
Median 5Y
1.9
Industry
1.2
Forward
1.2
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
91
vs Industry
66
Median 3Y
2.9
Median 5Y
3
Industry
4.1
More Details
5.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.1
vs History
91
vs Industry
57
Median 3Y
7
Median 5Y
7.3
Industry
11
Forward
7
More Details
8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8
vs History
91
vs Industry
48
Median 3Y
9.1
Median 5Y
9.8
Industry
14.3
Forward
15.1
More Details
6
EV/OCF
EV/OCF
Enterprise Value to OCF
6
vs History
91
vs Industry
48
Median 3Y
16.4
Median 5Y
17.2
Industry
11
More Details
7.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.3
vs History
91
vs Industry
41
Median 3Y
22.9
Median 5Y
26.6
Industry
13.4
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
95
vs Industry
32
Median 3Y
2.2
Median 5Y
2.5
Industry
1.1
More Details

Multiples Across Competitors

DOCS Competitors Multiples
Dr Martens PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Dr Martens PLC
LSE:DOCS
704.8m GBP 0.8 10.2 5.1 8
US
Nike Inc
NYSE:NKE
114.3B USD 2.3 23.4 18 20.6
US
Deckers Outdoor Corp
NYSE:DECK
31.6B USD 6.8 36.1 26.7 28.4
CH
On Holding AG
NYSE:ONON
18.1B USD 7.5 129.3 53.8 79.8
JP
Asics Corp
TSE:7936
2.2T JPY 3.4 37 20.1 24.2
CN
Huali Industrial Group Co Ltd
SZSE:300979
88.5B CNY 3.8 23.5 17.3 17.3
UK
Birkenstock Holding PLC
NYSE:BIRK
11.3B USD 6 56.5 21.9 27
US
Skechers USA Inc
NYSE:SKX
10.2B USD 1.2 16.2 8.3 10.3
DE
Puma SE
XETRA:PUM
6.8B EUR 0.8 25.8 12.9 12.9
US
Crocs Inc
NASDAQ:CROX
6.6B USD 1.6 7.9 7.2 7.6
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
131.3B TWD 1.5 23.4 12.3 17.2
P/E Multiple
Earnings Growth P/E to Growth
UK
Dr Martens PLC
LSE:DOCS
Average P/E: 35.4
10.2
-5%
N/A
US
Nike Inc
NYSE:NKE
23.4
-5%
N/A
US
Deckers Outdoor Corp
NYSE:DECK
36.1
49%
0.7
CH
On Holding AG
NYSE:ONON
129.3
456%
0.3
JP
Asics Corp
TSE:7936
37
149%
0.2
CN
Huali Industrial Group Co Ltd
SZSE:300979
23.5
60%
0.4
UK
Birkenstock Holding PLC
NYSE:BIRK
56.5
N/A N/A
US
Skechers USA Inc
NYSE:SKX
16.2
61%
0.3
DE
Puma SE
XETRA:PUM
25.8
62%
0.4
US
Crocs Inc
NASDAQ:CROX
7.9
2%
4.1
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
23.4
66%
0.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Dr Martens PLC
LSE:DOCS
Average EV/EBITDA: 18.5
5.1
6%
0.9
US
Nike Inc
NYSE:NKE
18
-5%
N/A
US
Deckers Outdoor Corp
NYSE:DECK
26.7
49%
0.5
CH
On Holding AG
NYSE:ONON
53.8
172%
0.3
JP
Asics Corp
TSE:7936
20.1
109%
0.2
CN
Huali Industrial Group Co Ltd
SZSE:300979
17.3
91%
0.2
UK
Birkenstock Holding PLC
NYSE:BIRK
21.9
N/A N/A
US
Skechers USA Inc
NYSE:SKX
8.3
49%
0.2
DE
Puma SE
XETRA:PUM
12.9
30%
0.4
US
Crocs Inc
NASDAQ:CROX
7.2
3%
2.5
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
12.3
61%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Dr Martens PLC
LSE:DOCS
Average EV/EBIT: 23
8
-5%
N/A
US
Nike Inc
NYSE:NKE
20.6
-4%
N/A
US
Deckers Outdoor Corp
NYSE:DECK
28.4
48%
0.6
CH
On Holding AG
NYSE:ONON
79.8
172%
0.5
JP
Asics Corp
TSE:7936
24.2
N/A N/A
CN
Huali Industrial Group Co Ltd
SZSE:300979
17.3
65%
0.3
UK
Birkenstock Holding PLC
NYSE:BIRK
27
N/A N/A
US
Skechers USA Inc
NYSE:SKX
10.3
56%
0.2
DE
Puma SE
XETRA:PUM
12.9
42%
0.3
US
Crocs Inc
NASDAQ:CROX
7.6
2%
4.8
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
17.2
73%
0.2

See Also

Summary
DOCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCS stock valuation using valuation multiples.
Wall Street Estimates
DOCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.